Genetic Breast Cancer Risk Test
Full Price
195€
- Recommended from the age of 30; the genetic test only needs to be taken once in a lifetime.
- The test is performed using a simple cheek swab.
- You will receive your results within 6 weeks. Doctors can also access the results through the Estonian Health Portal (Terviseportaal).
- Any further breast examinations may be provided free of charge through referrals under the national breast cancer screening programme.
- We offer the option of a post-test consultation.
Why is personalised cancer prevention important?
- Breast cancer often has a genetic component. Every woman’s risk of developing the disease is different. Women with a high genetic risk may develop breast cancer as early as their 30s or 40s, and the disease may be more aggressive at a younger age. This must be carefully considered when planning screening and follow-up examinations.
- Breast cancer and related deaths can often be prevented through timely measures, even before symptoms appear. When detected early, breast cancer is treatable.
- New technologies make it possible to identify genetic risk even in women who have no family history of breast cancer or no previously identified genetic mutations.
- With this service, you will receive a personalised medical prevention plan that takes into account your genetic profile, age, sex and ethnic background.
Who can benefit from this service?
- Women under 50: Particularly beneficial for identifying individual risk and starting regular screening years before the national screening programme begins.
- Women with no family history of breast cancer: The service is also suitable for women whose close relatives have never had cancer. Genetic risk may still be elevated, and innovative polygenic risk score (PRS) technology can now help identify it.
- Women with a family history of breast cancer: If breast cancer has occurred repeatedly among close relatives, we can also provide a free referral to a medical geneticist, if necessary, to investigate hereditary genetic risks in greater detail. The need for a referral is assessed based on a relevant questionnaire.
- If you have already consulted a geneticist but no known mutations have been identified, Antegenesis’ innovative technology can provide additional insight into your genetic risk.
- Women aged 50 and over: The service is also suitable for women already participating in the national screening programme. You can find out whether you may need more frequent monitoring than the screening programme’s standard interval of once every two years.
What does the service include?
- The service is based on genetic risk testing using innovative polygenic risk score (PRS) technology in healthcare.
- Antegenesis’ advanced, evidence-based PRS technology calculates the combined effect of 2,803 genetic variants associated with breast cancer to determine your genetic risk level.
- By combining your PRS result with your personal background (ethnicity, age and sex), we provide accurate risk assessments and personalised medical recommendations for further screening and healthy lifestyle choices, helping to prevent breast cancer and detect it at an early stage.
- The test is simple and convenient. All you need to do is collect a sample from the inside of your cheek using a cotton swab.
What will the test results tell you?
Your results will include:
- Your polygenic breast cancer risk score.
- An interpretation of your test results, together with clinical recommendations for prevention and screening and clear next steps.
- An estimate of your likelihood of developing breast cancer over the next 10 years, compared with a woman at average risk.
- A comprehensive set of clinical guidelines for healthcare professionals to support evidence-based, personalised breast cancer prevention and appropriate medical follow-up.
- An optional post-test consultation, during which you can discuss your genetic risk in combination with lifestyle-related risk factors.
Book an appointment for the test with a midwife at a breast clinic, a gynaecologist or a breast specialist (mammologist).